Jeonjinbio Co., Ltd. (KOSDAQ:110020)
South Korea · Delayed Price · Currency is KRW 1,760.00
+27.00 (1.56%)
At close: Jun 30, 2026
Jeonjinbio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.64 | -195.81 | 4,346 | -6,440 | -3,113 | -2,108 |
Depreciation & Amortization | 553.08 | 535.55 | 1,342 | 1,835 | 1,392 | 367.09 |
Loss (Gain) From Sale of Assets | -1.09 | -1.09 | 456.58 | -9.94 | - | 2.91 |
Asset Writedown & Restructuring Costs | 3.16 | 3.16 | 254.15 | 636.91 | - | - |
Provision & Write-off of Bad Debts | - | - | - | - | 27.28 | - |
Other Operating Activities | 99.23 | 17.99 | -3,788 | 4,498 | -274.25 | -519.84 |
Change in Accounts Receivable | 544.78 | 422.95 | 351.29 | -2,079 | -546.26 | -110.86 |
Change in Inventory | 588.81 | -17.62 | 818.8 | 287.03 | -1,357 | -308.04 |
Change in Accounts Payable | 175.7 | -180.8 | 20.4 | 100.56 | 91.34 | 27.89 |
Change in Other Net Operating Assets | -281.57 | -101.14 | -796.43 | 870.18 | 69.61 | 264.45 |
Operating Cash Flow | 1,699 | 483.19 | 3,005 | -300.6 | -3,710 | -2,385 |
Operating Cash Flow Growth | -13.59% | -83.92% | - | - | - | - |
Capital Expenditures | -667.59 | -789.08 | -389.47 | -660.35 | -1,995 | -1,848 |
Sale of Property, Plant & Equipment | 1.09 | 1.09 | 9.33 | 37.82 | - | 0.59 |
Sale (Purchase) of Intangibles | -1.67 | -1.67 | -4.88 | -11.3 | -134.25 | -85.3 |
Investment in Securities | - | - | - | 600 | -600 | - |
Other Investing Activities | 0.12 | 480 | 1,140 | 0.3 | -1,577 | 74.37 |
Investing Cash Flow | -668.05 | -309.66 | 755.05 | -33.52 | -4,306 | -1,858 |
Short-Term Debt Issued | - | - | - | 2,500 | - | - |
Long-Term Debt Issued | - | - | 3,100 | - | - | 11,300 |
Total Debt Issued | - | - | 3,100 | 2,500 | - | 11,300 |
Short-Term Debt Repaid | - | - | -2,500 | - | - | - |
Long-Term Debt Repaid | - | -43.97 | -786.75 | -2,206 | -7,726 | -670.92 |
Total Debt Repaid | - | -43.97 | -3,287 | -2,206 | -7,726 | -670.92 |
Net Debt Issued (Repaid) | - | -43.97 | -186.73 | 293.66 | -7,726 | 10,629 |
Issuance of Common Stock | - | - | 997.73 | 400 | 1,798 | - |
Other Financing Activities | - | - | -0 | -0 | - | -0 |
Financing Cash Flow | - | -43.97 | 811 | 693.66 | -5,928 | 10,629 |
Foreign Exchange Rate Adjustments | -3.16 | 6.72 | 12.25 | -1.53 | -27.16 | -3.14 |
Net Cash Flow | 1,028 | 136.27 | 4,583 | 358 | -13,971 | 6,383 |
Free Cash Flow | 1,031 | -305.9 | 2,616 | -960.95 | -5,705 | -4,232 |
Free Cash Flow Margin | 7.15% | -2.23% | 13.57% | -6.13% | -73.19% | -131.67% |
Free Cash Flow Per Share | 114.05 | -33.77 | 303.93 | -131.91 | -866.77 | -682.57 |
Cash Interest Paid | - | 0.33 | 68.28 | 193.49 | 482.41 | 56.48 |
Cash Income Tax Paid | 2.08 | -0.54 | 4.12 | -10.61 | 12.94 | 4.19 |
Levered Free Cash Flow | 808.59 | -259.71 | -2,037 | 1,821 | -10,832 | 577.6 |
Unlevered Free Cash Flow | 808.59 | -259.51 | -1,767 | 2,568 | -9,561 | 1,119 |
Change in Working Capital | 1,028 | 123.39 | 394.06 | -821.23 | -1,742 | -126.55 |